Researcher
Yannick Vandenplas
- Disciplines:Pharmacology not elsewhere classified, Pharmaco-economics
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From13 Aug 2019 → Today
Projects
1 - 1 of 1
- A Belgian policy framework for best-value biological medicinesFrom3 Sep 2019 → 18 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 11
- A Belgian policy framework for best-value biological medicines(2023)
Authors: Yannick Vandenplas, Isabelle Huys, Steven Simoens, Arnold Vulto
- The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis(2023)
Authors: Yannick Vandenplas, Steven Simoens, Arnold Vulto, Isabelle Huys
- How to select a best-value biological medicine? A practical model to support hospital pharmacists(2022)
Authors: Liese Barbier, Yannick Vandenplas, Isabelle Huys, Arnold Vulto
Pages: 2001 - 2011 - Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study(2022)
Authors: Yannick Vandenplas, Steven Simoens, Arnold Vulto, Isabelle Huys
- How to balance valuable innovation with affordable access to medicines in Belgium?(2022)
Authors: Steven Simoens, Khadidja Abdallah, Liese Barbier, Teresa Barcina Lacosta, Alessandra Blonda, Elif Car, Evelien De Sutter, Rosanne Janssens, Teodora Lalova-Spinks, Robbe Saesen, et al.
- Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care(2022)
Authors: Yannick Vandenplas, Liese Barbier, Steven Simoens, Arnold Vulto, Isabelle Huys
- Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians(2021)
Authors: Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold Vulto, Isabelle Huys
- Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis(2021)
Authors: Yannick Vandenplas, Steven Simoens, Arnold Vulto, Isabelle Huys
- Informing Patients about Biosimilar Medicines: The Role of European Patient Associations(2021)
Authors: Yannick Vandenplas, Steven Simoens, Arnold Vulto, Isabelle Huys
- Biosimilars in Oncology – Part II: Considerations about the clinical use of oncology biosimilars(2020)
Authors: Liese Barbier, Evelien Moorkens, Yannick Vandenplas, Arnold Vulto
Pages: 286 - 292